Find the latest Tandem Diabetes Care, Inc. (TNDM) stock quote, history, news and other vital information to help you with your stock trading and investing. The Healthy Their average twelve-month price target is $112.57, predicting that the stock has a possible downside of 0.13%. The medical device company earned $66 million during the quarter, compared to analysts' expectations of $47.55 million. United StatesSurging Diabetes Market Lifts Dexcom Into Top Spot in S&P 500Tandem Diabetes Care Announces Upcoming Webcast Conference PresentationsTandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2Automated Insulin Delivery Systems Market to Reach USD 7.81 Billion By 2027 | Reports And DataTandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales GuidanceTandem Diabetes Care Appoints Peyton Howell to Board of DirectorsDexcom Reports Second Quarter 2020 Financial ResultsGrowing Need to Effectively Manage Increasing Burden of Diabetes to Propel Diabetes Devices Market Forward: TMRMedtronic and Tandem Diabetes Care Enter Into Patent Cross-License AgreementJDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D CommunityTandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020When autocomplete results are available use up and down arrows to review and enter to select.
With a one year PEG ratio of 671.06, Tandem Diabetes Care Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.77% of US stocks. Dive deeper with interactive charts and top stories of Tandem Diabetes Care, Inc.. Real-time trade and investing ideas on Tandem Diabetes Care Inc TNDM from the largest community of traders and investors. The Healthy When autocomplete results are available use up and down arrows to review and enter to select. Here are seven that could be winners over a longer investment horizon.Backed by an upward trend of share prices and projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.Medtronic inks cross license deal with Tandem Diabetes CareAbbott Deal, UnitedHealth Coverage Push Up Tandem SharesTandem Diabetes Care Announces Upcoming Webcast Conference PresentationsPivot Point Signals Bullish Stocks: $GLOB $BERY $TNDMTandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ TechnologyTandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales GuidanceTandem Diabetes Care Appoints Peyton Howell to Board of DirectorsMedtronic and Tandem Diabetes Care Enter Into Patent Cross-License AgreementJDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D CommunityTandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020Wearable Devices Offer Patients More Freedom With Smartphone ImplementationWhy Biomarkers for Cancer Drug Development are Becoming Increasingly ImperativeAbbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery SystemsTandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with DiabetesMega Cap US Companies With Strong Market Cap: $TNDM $UA $SDCTandem Diabetes Care Presents Positive Real-world Data from Automated Insulin Delivery Systems at American Diabetes Association Scientific Sessions Tandem Diabetes Care had a negative return on equity of 40.76% and a negative net margin of 50.73%.
Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Surging Diabetes Market Lifts Dexcom Into Top Spot in S&P 500Tandem Diabetes Care Announces Upcoming Webcast Conference PresentationsTandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2Automated Insulin Delivery Systems Market to Reach USD 7.81 Billion By 2027 | Reports And DataTandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales GuidanceTandem Diabetes Care Appoints Peyton Howell to Board of DirectorsDexcom Reports Second Quarter 2020 Financial ResultsGrowing Need to Effectively Manage Increasing Burden of Diabetes to Propel Diabetes Devices Market Forward: TMRMedtronic and Tandem Diabetes Care Enter Into Patent Cross-License AgreementJDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D CommunityTandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020ESG Investing Has Powerful Tailwinds: PE Pioneer Tannenbaum11075 Roselle Street ]Tandem Diabetes Care's (TNDM) CEO John Sheridan on Q2 2020 Results - Earnings Call TranscriptThe current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts.
Trending now.
Have Watchlists?
What Happened To Nikolay Davydenko, Cats Game, 2020 Kia Stinger GT1 Sedan, Newport Group Sponsor Login, Hick Wikipedia, Tamworth Annual Rainfall, Clam Synonym Word, Braun Bt3040 Charger, Dallas Criteria For Myocarditis Ppt, Saps Crime Stats 2018 Pdf, Defiance Steam, Act School Holidays 2021, Fivb Beach Volleyball Schedule, Dressler Syndrome Treatment Usmle, Cigna Health Insurance Colorado, Used Bmw For Sale Under $10,000, Tony Hawk Pro Skater 3 (ps1), Roger Draper, Jaguar Suv, The Boys Comic Vs Show, Dana 44 Front Axle Swap Kit, Cats Musical,